Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...

A positive mindset and resilience are crucial in overcoming the challenges of a cancer diagnosis and can be cultivated ...

Many childhood cancer survivors do not receive essential follow-up care, and researchers from the Keck School of Medicine of ...

Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...

Discover inspiring messages of hope from cancer survivors, emphasizing resilience, scientific advancements, and the ...

Explore the evolving landscape of myeloma treatment, focusing on maintenance therapies and patient experiences with ...

The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application for a registrational phase 3 clinical trial of iSCIB1+ for patients with advanced melanoma, a step that ...

Treatment for stage 2 essential thrombocythemia is highly personalized. Not every patient requires medication right away, and ...

Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...

Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...

Updated NCCN Clinical Practice Guidelines in Oncology now recognize that MammaPrint and BluePrint testing can help identify a ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...